Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying potential drug targets for myocardial infarction through Mendelian randomization.

PloS one - 1 Jan 2024

Yu Xiangyou, Liu Shasha

Abstract excerpt

BACKGROUND: This study explored the associations between plasma and cerebrospinal fluid (CSF) proteins and myocardial infarction (MI) risk. Identifying specific proteins as biomarkers for MI could enhance our understanding of disease mechanisms and inform clinical practice. METHODS: We combined protein quantitative trait loci (pQTL) data for plasma and CSF proteins with genome-wide association study (GWAS)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bayes Theorem
Share to Biomarkers
Share to Genome-Wide Association Study

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mendelian Randomization Analysis

Share to Myocardial Infarction

Share to Polymorphism, Single Nucleotide

Share to Quantitative Trait Loci

Source

Open in PubMed Open full text

Identifiers

PMID: 39715222
DOI: 10.1371/journal.pone.0313770
PMCID: PMC11665999

Genes

CD8A
DPEP1
HDHD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying potential drug targets for myocardial infarction through Mendelian randomization.PMID 39715222Read ↗

Potential drug targets for myocardial infarction identified through Mendelian randomization analysis and Genetic colocalization.Semantic proximity Read ↗

Proteome-wide Mendelian Randomization Analysis Identified Potential Drug Targets for Myocardial InfarctionSemantic proximity Read ↗

Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarctionSemantic proximity Read ↗

Multiomics Mendelian Randomization of GWAS, eQTL, and pQTL Combined With Drug Analysis to Predict Drug Targets in Myocardial Infarction.Semantic proximity Read ↗

Proteome-wide Mendelian randomization identifies candidate causal proteins for cardiovascular diseasesSemantic proximity Read ↗

Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke.Semantic proximity Read ↗

Cross-population proteome-wide mendelian randomization study identifies likely causal proteins for cardiovascular diseases.Semantic proximity Read ↗

Identifying Potential Drug Targets in Coronary Atherosclerosis: Insights from the Druggable Genome and Mendelian Randomization.Semantic proximity Read ↗

Novel Drug Targets for Atrial Fibrillation Identified Through Mendelian Randomization Analysis of the Blood Proteome.Semantic proximity Read ↗

Exploring Potential Drug Targets in Multiple Cardiovascular Diseases: A Study Based on Proteome‐Wide Mendelian Randomization and Colocalization AnalysisSemantic proximity Read ↗

Therapeutic protein targets for cardiometabolic diseases: Mendelian randomization integrating plasma proteomes with genome-wide association dataSemantic proximity Read ↗

Genetically predicted levels of the human plasma proteome and risk of stroke: a Mendelian Randomization studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.